Frequently Asked Questions 1 2 PROST BIOTECH SDN BHD Evidence-based educational resources for metabolic health and cellular optimization
Recommend 100% Great service and great product
Phase 1 (Weeks 1 to 2): 0.25 mg subcutaneous injection once daily, morning on empty stomach Phase 2 (Weeks 3 to 6): Maintain 0.25 mg or increase to 0.5 mg based on response and tolerance Phase 3 (Weeks 7 to 8): Continue or begin taper depending on symptom improvement Maintenance: Consider cycling 4 weeks on, 2 weeks off for long-term management Oral dosing requires higher amounts to compensate for bioavailability differences
What is the shelf life
ACS Appl Materials Interfaces
[DOI] [PMC free article] [PubMed] [Google Scholar] 83.Sikiric P., Drmic D., Sever M., Klicek R., Blagaic A.B., Tvrdeic A., Kralj T., Kovac K.K., Vukojevic J., Siroglavic M., et al